Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo  >  Mitsubishi Chemical Holdings Corporation    4188   JP3897700005

MITSUBISHI CHEMICAL HOLDINGS CORPORATION

(4188)
  Report  
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Mitsubishi Chem to spend $4.5 billion to buy rest of Mitsubishi Tanabe

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/18/2019 | 02:47am EST

Mitsubishi Chemical Holdings Corp, Japan's largest chemical maker, said on Monday it will pay 491.8 billion yen ($4.51 billion) to make Mitsubishi Tanabe Pharma Corp a fully owned subsidiary.

Mitsubishi Chemical will offer 2,010 yen for each share it doesn't already own in Mitsubishi Tanabe, it said in a statement to the Tokyo Stock Exchange. That is a 50% premium to the drugmaker's closing price of 1,338 yen per share in Tokyo trading.

The chemical maker already held more than 56% of shares in Mitsubishi Tanabe, Japan's eighth largest drugmaker by revenue, according to Refinitiv data.

The Osaka-based pharma company was the product of a 2007 merger between Mitsubishi Pharma Corp and Tanabe Seiyaku. It focuses on autoimmune, diabetes, renal and central nervous system treatments.

(Reporting by Rocky Swift; Editing by Muralikumar Anantharaman)

Stocks mentioned in the article
ChangeLast1st jan.
MITSUBISHI CHEMICAL HOLDINGS CORPORATION 0.95% 827 End-of-day quote.1.85%
MITSUBISHI CORPORATION 0.48% 2936 End-of-day quote.-0.94%
MITSUBISHI TANABE PHARMA CORPORATION 0.05% 2003 End-of-day quote.29.81%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MITSUBISHI CHEMICAL HOLDIN
11/18Mitsubishi Chem to spend $4.5 billion to buy rest of Mitsubishi Tanabe
RE
11/12MITSUBISHI TANABE PHARMA CORPORATION : - HIF-PH Inhibitor Vadadustat Japan Phase..
AQ
11/12MITSUBISHI TANABE PHARMA CORPORATION : Announces Results of the MT-7117 ENDEAVOR..
AQ
11/01MITSUBISHI CHEMICAL : Consolidated Financial Information for the First Half of t..
PU
11/01MITSUBISHI CHEMICAL : Notice on Revision to Consolidated Financial Results Forec..
PU
11/01MITSUBISHI CHEMICAL HOLDINGS CORPORA : Half-year results
CO
10/29MITSUBISHI CHEMICAL HOLDINGS CORPORA : half-yearly earnings release
10/10TAIYO NIPPON SANSO : to triple nitrogen output capacity in Singapore
AQ
09/27MITSUBISHI CHEMICAL HOLDINGS CORP. : Ex-dividend day for interim dividend
FA
09/26MITSUBISHI CHEMICAL : MCHC Group Corporate Venture Activity Diamond Edge Venture..
AQ
More news
Financials (JPY)
Sales 2020 3 729 B
EBIT 2020 243 B
Net income 2020 133 B
Debt 2020 2 339 B
Yield 2020 4,73%
P/E ratio 2020 8,94x
P/E ratio 2021 8,60x
EV / Sales2020 0,94x
EV / Sales2021 0,87x
Capitalization 1 174 B
Technical analysis trends MITSUBISHI CHEMICAL HOLDIN
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 845,91  JPY
Last Close Price 827,10  JPY
Spread / Highest target 33,0%
Spread / Average Target 2,27%
Spread / Lowest Target -39,5%
EPS Revisions
Managers
NameTitle
Hitoshi Ochi President & Director
Yoshimitsu Kobayashi Chairman
Hidefumi Date CFO & Managing Executive Officer
Hisao Urata Director
Glenn H. Fredrickson Director
Sector and Competitors
1st jan.Capitalization (M$)
MITSUBISHI CHEMICAL HOLDINGS CORPORATION1.85%10 701
BASF SE13.06%69 307
DUPONT DE NEMOURS, INC.-14.96%47 108
SHIN-ETSU CHEMICAL CO., LTD.43.03%45 076
ROYAL DSM61.39%21 516
GROUPE BRUXELLES LAMBERT22.34%16 053